Liquidia Corp (LQDA) stock
LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.73+0.36 (+0.64%)
Close on Nov 17, 2026Market cap $5.08BP/E 40.8Yield –
Liquidia EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Liquidia's EPS for the twelve months ending Jun 30, 2026 was $1.39. For fiscal 2025 it was -$0.80. The highest annual figure on record is -$0.67 in fiscal 2022.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.80 | – |
| FY2024 | Dec 31, 2024 | -$1.63 | – |
| FY2023 | Dec 31, 2023 | -$1.21 | – |
| FY2022 | Dec 31, 2022 | -$0.67 | – |
| FY2021 | Dec 31, 2021 | -$0.70 | – |
| FY2020 | Dec 31, 2020 | -$1.76 | – |
| FY2019 | Dec 31, 2019 | -$2.57 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0.74 | – |
| Q1 FY2026 | Mar 31, 2026 | $0.52 | – |
| Q4 FY2025 | Dec 31, 2025 | $0.17 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.04 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.49 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.45 | – |
| Q4 FY2024 | Dec 31, 2024 | -$0.45 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.40 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.38 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.40 | – |
| Q4 FY2023 | Dec 31, 2023 | -$0.42 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.24 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.36 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.18 | – |
| Q4 FY2022 | Dec 31, 2022 | -$0.10 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.14 | – |
| Q2 FY2022 | Jun 30, 2022 | -$0.15 | – |
| Q1 FY2022 | Mar 31, 2022 | -$0.30 | – |
| Q4 FY2021 | Dec 31, 2021 | -$0.22 | – |
| Q3 FY2021 | Sep 30, 2021 | -$0.14 | – |
| Q2 FY2021 | Jun 30, 2021 | -$0.13 | – |
| Q1 FY2021 | Mar 31, 2021 | -$0.21 | – |
| Q4 FY2020 | Dec 31, 2020 | -$0.39 | – |
| Q3 FY2020 | Sep 30, 2020 | -$0.40 | – |
| Q2 FY2020 | Jun 30, 2020 | -$0.49 | – |
| Q1 FY2020 | Mar 31, 2020 | -$0.52 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?